COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Gladstone Investment Corporation Earnings Call and Webcast Information
Gladstone Investment Corporation (Nasdaq: GAIN) announces Third Fiscal Quarter Ended December 31, 2023 Earnings Call & Webcast on February 7, 2024 at 8:30 a.m. ET. For further details, please visit their website -
-
COMMUNIQUÉ DE PRESSE
Boron One Granted New Exploration License as it Progresses Through Exploitation Approvals
Boron One Holdings Inc. has been granted a new 3-year exploration license by the Serbian Ministry of Mining and Energy for its Piskanja Boron Project, ensuring continued exclusive rights and potential expansion of the known mineral resource. The company is progressing through the mineral exploitation approval process for Piskanja -
COMMUNIQUÉ DE PRESSE
Labor Smart Inc., LTNC, Next Gen Beverages Launches New eSports Division
Labor Smart, Inc. announces the launch of its new eSports Gaming Division through its subsidiary, Next Gen Beverages, offering opportunities for gamers and aligning with the growing eSports phenomenon. The company encourages gaming enthusiasts to join the affiliate program and learn about the innovative LOCK'DIN products -
COMMUNIQUÉ DE PRESSE
Tharimmune Announces Dosing of First Patient in Phase 1 Clinical Trial of TH104, its Lead Candidate for Pruritus in Primary Biliary Cholangitis
Tharimmune, Inc. completes first patient dosing in Phase 1 clinical trial for TH104, an oral thin film targeting liver-related and pruritogenic inflammatory conditions. Topline data expected in 2Q24 with full readout shortly after. Company fully funded into 2025 for Phase 1 and 2 readouts -
COMMUNIQUÉ DE PRESSE
Form 8.3 - The Vanguard Group, Inc.: abrdn Property Income Trust Limited
The Vanguard Group, Inc. discloses 1.05% interest in abrdn Property Income Trust Limited's 1p ordinary class of relevant securities. Details of the disclosure are provided in Form 8.3 submitted on 5th February 2024 -
COMMUNIQUÉ DE PRESSE
ARRALYZE® Launches CellShepherd®: A Fully Autonomous Single-Cell Platform For Real-Time Monitoring Of Functional Assays
LPKF's ARRALYZE® introduces CellShepherd®, a revolutionary platform for single-cell analysis, meeting the demand for advanced cell screening technologies in life science research -
COMMUNIQUÉ DE PRESSE
Dr. Serkan Aygin Clinic Opens a Miami Branch Office
Dr. Serkan Aygin Clinic's Miami branch office is now open, offering free hair transplant consultations. The clinic provides top-notch results with innovative methods and personalized services, including Sapphire FUE and DHI techniques. Contact for appointments -
COMMUNIQUÉ DE PRESSE
WallabyPhenox Boldly Sets New Benchmark in Evidence-Based Medicine With the PROST Trial
WallabyPhenox announces the publication of PROST trial results in JAMA Neurology, marking a significant advancement in stroke treatment. The trial confirms the non-inferiority and safety of the pRESET thrombectomy device, with potential to reduce disability in large vessel occlusion stroke patients
